SEO Description: Evaluate D-ribose powder purity, COA parameters, formulation risks, regulatory status, packaging, samples, and bulk sourcing requirements.
Suggested Alt Text: Bulk D-ribose powder with specification sheet, sample packaging, and laboratory quality testing for commercial sourcing
D-Ribose Powder: Specifications, Uses & Bulk Sourcing Guide
D-ribose powder is a water-soluble five-carbon monosaccharide used in sports nutrition powders, beverage mixes, capsules, tablets and specialized nutrition products. Commercial buyers should evaluate more than a headline purity percentage. HPLC assay, specific optical rotation, related sugars, moisture, water activity, particle size and microbiological quality can all affect raw-material approval and production performance.
The ingredient also requires application testing. Moisture exposure can reduce powder flow, while D-ribose may participate in Maillard reactions when combined with proteins, peptides or amino acids.
Essencefield supports B2B projects through specification matching, representative samples, document review and bulk supply planning. Buyers can review the current D-Ribose Powder product information before requesting a specification, sample COA or quotation.
D-Ribose Powder Sourcing Summary
| Item | Typical published option |
|---|---|
| Product name | D-Ribose Powder |
| CAS number | 50-69-1 |
| Molecular formula | C₅H₁₀O₅ |
| Molecular weight | 150.13 g/mol |
| Appearance | White to off-white crystalline powder |
| Typical assay | D-ribose ≥99.0% by HPLC |
| Standard particle size | Commonly 80 mesh |
| Carrier | Typically carrier-free |
| Standard MOQ | Typically from 25 kg |
| Sample quantity | Commonly 100 g–1 kg |
| Standard lead time | Typically 7–15 working days |
| Typical shelf life | 24 months unopened |
| Standard documents | COA, specification, TDS and SDS |
Specifications, documents and commercial terms are confirmed against the approved application, target market and order requirements. Related carbohydrate raw materials can be reviewed in Essencefield’s sugar ingredient category.
Identity, Manufacturing and Grade Selection
D-ribose is an aldopentose monosaccharide with the molecular formula C₅H₁₀O₅. It is a structural component of ribonucleotides, including adenosine monophosphate, adenosine diphosphate and adenosine triphosphate.
Its role in nucleotide and ATP metabolism explains its use in cellular-energy and sports nutrition concepts. However, biochemical involvement does not establish that every finished product containing D-ribose improves energy, recovery or exercise performance.
Product developers should separate:
- Established biochemical function
- Findings from individual human studies
- Claims permitted in the destination market
- Evidence generated for the complete formulation
D-ribose must also be distinguished from deoxyribose, ribose-5-phosphate and nicotinamide riboside. These substances have different chemical identities, functions and regulatory classifications.
Commercial Manufacturing
Bulk D-ribose powder is generally produced through fermentation or controlled bioconversion, followed by purification and crystallization.
A simplified process is:
Feedstock preparation → fermentation → clarification → purification → crystallization and drying → sieving and batch release
Critical process controls include purification efficiency, related-sugar removal, drying conditions, particle-size control and batch traceability.
The material evaluated by the European Food Safety Authority was manufactured by fermentation using a transketolase-deficient strain of Bacillus subtilis. That description applies to the material assessed by EFSA and should not automatically be attributed to every commercial source. The complete assessment is available in the EFSA scientific opinion on D-ribose.
During supplier qualification, buyers should verify the production route, manufacturing site, feedstock, production-organism status and impurity-control strategy for the proposed material.
Food Grade, Supplement Grade and USP Claims
Food grade, dietary supplement grade and pharmaceutical grade are not interchangeable guarantees.
A grade designation should be supported by:
- An approved specification
- Defined analytical methods
- Appropriate manufacturing controls
- Market-specific contaminant limits
- Application-specific microbiological criteria
- Suitable packaging and storage conditions
When USP compliance is claimed, buyers should evaluate the complete applicable monograph. The USP–NF Ribose monograph specifies a dried-basis D-ribose content of 98.0%–102.0%, but a 99% assay result alone does not establish full compendial compliance.
Critical D-Ribose Powder Specifications
An effective purchasing specification should connect every analytical parameter with a material, manufacturing or food-safety risk.
| Parameter | Buyer review | Procurement significance |
|---|---|---|
| Identification | HPLC, optical rotation, FTIR or agreed method | Confirms the correct chemical |
| Assay | Method, detector and calculation basis | Supports formula and label calculations |
| Specific optical rotation | Conditions and acceptance range | Supports D-isomer confirmation |
| Related sugars | Individual and total limits | Indicates purification and process consistency |
| Moisture | Method and maximum value | Affects caking and dry-basis assay |
| Water activity | Report where physically relevant | Helps predict humidity-related instability |
| Residue on ignition | Defined maximum | Indicates inorganic residue |
| Particle size | Mesh or full distribution | Affects dissolution, flow and dusting |
| Bulk density | Loose and tapped values where required | Affects filling and package volume |
| Elemental impurities | Element-specific limits | Supports safety and market compliance |
| Microbiology | Numerical limits and sampling plan | Supports application-specific release |
| Pathogens | Negative under defined sampling | Supports ingredient safety |
HPLC Assay
A typical commercial specification may state D-ribose content of at least 99.0% by HPLC. Buyers should also determine:
- Whether the result is reported on an as-is or dry basis
- Which detector is used
- Which reference standard supports the test
- Whether related sugars are adequately separated
- Whether the method has been validated or verified
Two products described as “99% D-ribose” may differ in moisture, impurity profile and analytical methodology. Their headline results may therefore not be directly comparable.
Specific Optical Rotation
Assay and optical rotation provide different information.
Assay estimates the amount of D-ribose present. Specific optical rotation helps confirm that the material exhibits the expected stereochemical characteristics.
The European Union specification for authorized D-ribose lists a specific rotation of −19.0° to −21.0°. This can serve as a regulatory reference, although contractual conditions should be stated in the approved purchasing specification. The complete compositional and use requirements appear in Commission Implementing Regulation (EU) 2019/506.
Related Sugars
A high assay does not provide a complete impurity profile.
Related-sugar testing can reveal:
- Fermentation by-products
- Incomplete purification
- Storage-related degradation
- Differences between production routes
- Batch-to-batch process variation
For recurring supply, quality teams should compare chromatographic profiles and actual related-sugar results rather than reviewing only the final purity value.
Moisture and Water Activity
Moisture and water activity are related but not equivalent.
Loss on drying measures material removed under specified drying conditions. Water activity indicates how much water is available to influence physical stability and deterioration processes.
Both may be relevant to:
- Powder caking
- Hopper flow
- Sachet and stick-pack filling
- Open-container exposure
- Humid-market storage
- Long-distance transportation
A low moisture result does not independently guarantee good physical stability. Particle size, water activity, packaging barrier and warehouse humidity should be considered together.
Particle Size and Bulk Density
A common commercial particle-size option is 80 mesh, although finer, coarser or controlled distributions may be selected for individual projects.
Particle size influences:
- Dissolution rate
- Dust generation
- Blend uniformity
- Segregation
- Mouthfeel
- Hopper performance
Bulk and tapped density affect capsule fill weight, tablet die filling, sachet volume and package dimensions.
A chemically compliant material can still perform poorly if its physical properties do not match the intended process. Buyers should therefore include relevant physical parameters in sample and pilot-batch approval.
Elemental Impurities and Microbiology
Generic limits such as “total heavy metals” provide limited risk information. Buyers should request element-specific controls for lead, arsenic, cadmium and mercury based on the intended serving level and destination market.
Microbiological limits should reflect the final application. A dry-blended supplement, beverage powder and specialized nutrition product may require different total-count, yeast, mold and pathogen criteria.
Formulation and Stability Considerations
D-ribose dissolves readily in water, but commercial performance depends on concentration, particle size, humidity, surrounding ingredients and processing conditions.
Powder Flow and Caking
Exposure to moisture may cause:
- Agglomeration
- Reduced flowability
- Hopper bridging
- Inaccurate dosing
- Package caking
- Slower post-storage dissolution
A sample that flows well immediately after opening may behave differently after several hours in a humid production environment.
Pilot trials should consider room humidity, open-container exposure, filling speed, feeder design, anticaking strategy and inner-packaging performance.
Beverage Powder Dissolution
Particle size creates a practical balance between dissolution and handling.
Fine powder may dissolve quickly but create more dust and absorb moisture more readily. Coarser crystalline material may flow better but require additional mixing. Agglomerated material may be preferred where rapid wetting and dispersion are important.
Bench and pilot trials should evaluate:
- Water temperature
- Mixing speed
- Order of addition
- Use concentration
- Acids and final pH
- Electrolytes and minerals
- Sweeteners and flavors
- Hydrocolloids
- Holding time
Testing should use the complete commercial formula. A dilute beaker test may not predict behavior in a concentrated premix or full-scale vessel.
Compatibility with Proteins and Amino Acids
D-ribose is a reducing sugar and can react with amino groups in proteins, peptides and amino acids through Maillard chemistry.
This risk is relevant to:
- Whey and milk protein
- Plant proteins
- Collagen peptides
- Free-form amino acids
- Protein bars
- Heat-processed chews
- Intermediate-moisture foods
Possible effects include browning, flavor drift, odor development, texture changes and altered protein functionality.
Research involving whey protein isolate found that ribose promoted Maillard reactions and covalent protein cross-linking. The study can be reviewed through PubMed.
Reaction rate can be affected by temperature, water activity, pH, ingredient concentration and storage time. Stability testing should therefore be conducted with the complete formulation and intended packaging rather than with D-ribose in water alone.
Capsules and Tablets
Capsule and tablet trials should confirm:
- Powder flow
- Fill-weight consistency
- Compressibility
- Disintegration
- Moisture-related stability
Fine material may support blend uniformity but increase dusting and static. Density differences between ingredients may also contribute to segregation.
Physical performance should be included in raw-material approval when commercial production involves volumetric filling or compression.
Scientific, Regulatory and Claims Review
Human exercise studies have reported mixed outcomes across different populations and protocols. A randomized study in trained subjects did not find improved repeated high-intensity exercise capacity under its test conditions, while other studies have reported selected benefits in lower-fitness populations.
These differences do not support universal claims. Biochemical involvement in ATP metabolism should not be presented as proof of consistent performance benefits for every consumer or formulation.
United States
FDA GRAS Notice 243 describes D-ribose for use in specified food categories when used with an additional carbohydrate energy source. FDA responded that it had no questions regarding the notifier’s conclusion under the stated conditions.
The official conditions can be reviewed in FDA GRAS Notice 243.
This is not unrestricted FDA approval. Earlier GRN 100 did not reach the same conclusion, so US regulatory descriptions should reference GRN 243 and its stated uses.
Dietary supplement businesses must separately evaluate ingredient status, manufacturing requirements, labeling and proposed structure/function claims.
European Union
D-ribose is authorized as a novel food in the European Union. Its authorization establishes:
- Permitted food categories
- Maximum use levels
- Compositional requirements
- Ingredient designation
- Additional labeling conditions
The regulation requires the ingredient to be designated as “D-ribose” and includes a statement concerning same-day consumption with a food supplement containing D-ribose.
EFSA concluded that D-ribose was safe for the general population at intake levels up to 36 mg/kg body weight per day. It did not conclude that all originally proposed uses and intake levels were safe.
An EU product assessment should therefore confirm the permitted category, use level, intended population, labeling and total daily exposure.
Requirements in other countries should be reviewed market by market rather than inferred from US or EU status.
How to Qualify a D-Ribose Powder Supplier
Supplier approval should combine source verification, document review, analytical testing, application trials and commercial-batch confirmation.
1. Review the Source and Specification
Confirm:
- Contracting supplier
- Original manufacturer
- Manufacturing site
- Country of origin
- Production method
- Approved chemical and physical limits
- Change-notification expectations
Essencefield’s ingredient sourcing process includes requirement review, specification matching, preliminary document assessment, sample coordination and bulk supply planning.
2. Verify the Batch COA and Documents
A batch COA should correspond to the actual commercial lot and display:
- Product and grade name
- Batch or lot number
- Manufacturing date
- Retest or expiry date
- Approved specification limits
- Actual analytical results
- Test methods
- Quality authorization
“Conforms” may be acceptable for qualitative checks such as appearance. Quantitative tests such as assay, moisture and optical rotation should ordinarily report actual values.
The COA should be reviewed with the contractual specification, source information and product label. It should not be treated as standalone evidence of complete supplier qualification.
| Document | Primary purpose |
|---|---|
| Product specification | Defines contractual acceptance requirements |
| Batch COA | Reports actual lot results |
| TDS | Describes technical and physical properties |
| SDS | Provides handling and safety information |
| Origin statement | Supports source and import review |
| Allergen and GMO statements | Support quality and label assessment |
| Third-party report | Provides additional independent verification |
Essencefield’s raw-material quality process covers supplier review, specification approval, COA assessment, incoming inspection, release and traceability. Additional analytical support can be reviewed through its testing and certification resources.
3. Test a Representative Sample
Testing may include:
- Identity
- HPLC assay
- Specific optical rotation
- Related sugars
- Moisture
- Water activity
- Particle size
- Bulk density
- Elemental impurities
- Microbiology
- Appearance and solution clarity
The sample should represent routine commercial production rather than a specially prepared laboratory batch.
4. Conduct an Application Trial
For beverage powders, assess dissolution, caking and flavor impact. For capsules, evaluate flow and fill-weight variation. For tablets, confirm compression and disintegration. For protein systems, monitor browning and sensory stability.
Raw-material approval should be based on application performance as well as COA compliance.
5. Verify the First Commercial Batch
Compare the first commercial lot with:
- The approved specification
- The approved sample
- The supplier COA
- Internal laboratory results
- Physical-performance requirements
- Packaging condition
Repeat orders should be monitored for meaningful changes in assay, related sugars, moisture, water activity, particle size and sensory characteristics.
Packaging, Storage and Qualified Cost
D-ribose should be supplied in sealed, food-compatible packaging that protects it from moisture, contamination and odor transfer.
For humid destinations or extended freight routes, moisture-barrier liners and controlled dry-storage conditions may reduce caking and flow deterioration.
After opening, the package should be tightly resealed and stored away from heat, direct sunlight, humidity and strong odors.
Commercial offers should be compared using total qualified cost rather than price per kilogram alone. Relevant cost factors include:
- Independent testing
- Packaging
- Freight
- Import documentation
- Lead time
- Production performance
- Rejected-batch risk
- Supply consistency
A low-cost ingredient can become expensive if it causes retesting, poor filling performance, formulation instability or production delays.
Sourcing D-Ribose Powder
An effective sourcing request should identify:
- Intended product format
- Destination market
- Required assay and methods
- Particle-size requirements
- Expected order quantity
- Packaging preference
- Required documents
- Additional testing
- Target delivery schedule
This information allows the available grade, analytical limits, sample plan and commercial supply conditions to be reviewed before approval.
Final purchasing decisions should be based on the current specification, representative sample, application trial, batch-specific COA and market-specific regulatory assessment—not on a generic purity claim.
Contact Essencefield to request the current D-ribose powder specification, sample COA, representative sample and bulk quotation.

















